Blog & Commentary
Simmons Hanly Conroy’s support blog is a place for clients and families to find news, education, and inspirational stories about the following areas of litigation: mesothelioma and asbestos, dangerous drugs and devices, consumer protection and mass torts, personal injury and environmental litigation.
Blog
Male Pattern Baldness Linked to Increased Prostate Cancer Risk
Male pattern baldness has long been a source of anxiety for men, raising concerns of appearance and aging. Aside from aesthetic effects, though, it can have much more serious implications. An early… Read More
Pharmaceutical News Wrap Up: October 2014
The Simmons Hanly Conroy pharmaceutical lawyers are dedicated to providing you with the latest pharmaceutical news. Below is a short list of some of the most recent headlines concerning FDA recalls and… Read More
Blood Thinner Xarelto Linked to Life-Threatening Side Effects
This year, claims have been filed by patients and their family members who say the use of blood thinner Xarelto has led to serious, irreversible internal bleeding and death. The drug currently… Read More
Get to Know the Simmons Hanly Conroy Partners: Part 1
Earlier this summer, the Simmons Firm announced it’s merging with Hanly Conroy Bierstein Sheridan Fisher & Hayes LLP to become the now Simmons Hanly Conroy, effective on July 1. Not only did… Read More
Giving Back: Simmons Hanly Conroy and the National Park Trust
Some people are aware of the nearly $20 million Simmons Hanly Conroy has donated to cancer research, as well as its support of mesothelioma organizations like the Meso Applied Research Foundation. But… Read More
6 Lipitor Side Effects You May Not Be Aware Of
Like many pharmaceutical drugs, Lipitor can cause problems as serious as those it is solving. Lipitor is prescribed to lower ‘bad’ (LDL) cholesterol and triglycerides as well as to raise ‘good’ (HDL)… Read More
Pradaxa Manufacturer Pays $650 Million in a Comprehensive Settlement
Earlier this year, Boehringer Ingelheim, the manufacturer of Pradaxa (dabigatran), agreed to pay $650 million in a comprehensive settlement related to lawsuits issued by users of the drug. Reports of death, bleeding… Read More
FDA Advises Drugmakers to Conduct Further Studies on Testosterone Heart Risk
An advisory panel to the U.S. Food and Drug Administration (FDA) recently voted 20-1 that further assessment of the health risks of testosterone therapy is needed among drugmakers. Among the panel, 16… Read More
Risperdal, Weight Gain and Gynecomastia: The Connection
Risperdal is currently used to treat severe psychiatric disorders despite escalating reports of unhealthy weight gain and gynecomastia. Due to the drug’s success and its lack of proper warning, though, doctors continue to… Read More
Join the ADAO Mesothelioma Warrior Virtual Team
Not everyone who supports mesothelioma awareness may be able to attend Miles for Meso on Sept. 27. The Asbestos Disease Awareness Organization (ADAO) provides a solution to this with its ADAO Mesothelioma… Read More
